Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with HIV who added dolutegravir and maraviroc did not see an improvement in overall cognitive function.
As always, association does not equal causation. And clinical trials are already underway.
Meat, sugary beverages and whole milk were associated with more trouble thinking.
A new analysis suggests that the impact of HIV-associated neurocognitive disorders differs by sex, race, age and employment status.
Going hungry for a prolonged period raised the risk of declining mental performance.
In the context of universal health care, this may be a result of more frequent access to care.
In a well-insured cohort of older people with HIV, antiretroviral treatment didn’t offset the risk for dementia.
A study suggests cannabis use is linked to lower odds of neurocognitive problems in this population.
That’s compared with a control group of HIV-negative individuals in a small study.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
Findings suggest that the older class of HIV drugs may contribute to HIV-associated neurocognitive disorders.
A Campbell Foundation grant helps researches answer that question as they explore HIV-associated neurocognitive disorders (HAND).
Among a group of middle-aged men with well-treated HIV, there was also a link between cognitive decline and a gene connected to Alzheimer’s.
This man’s diagnosis could be an indicator of what is to come for an aging HIV population.
Clinicians at Georgetown University have reported the first case of a person living with HIV receiving a diagnosis of Alzheimer’s disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.